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Silica nanoparticles (SNPs) doped by hexanuclear molybdenum cluster complexes [{Mo6X8}L6]
n (X = Cl, Br,
or I; L = various inorganic or organic ligands) have been recently suggested as materials with high potential
for biomedical applications due to both their outstanding photoluminescence properties and their ability to
eﬃciently generate singlet oxygen upon photoirradiation. However, no studies were undertaken so far to
prove this concept. Therefore, here we examined the potential of photoluminescent SNPs doped by
{Mo6I8}
4+ for applications such as bioimaging and photodynamic therapy using the human epidermoid
larynx carcinoma (Hep-2) cell line as a model. Our results demonstrated both: (i) significant luminescence
from cells with internalised molybdenum cluster-doped SNPs combined with the low cytotoxicity of
particles in the darkness and (ii) significant cytotoxicity of the particles upon photoirradiation. Thus, this
research provides strong experimental evidence for high potential of molybdenum-cluster-doped materials
in biomedical applications such as optical bioimaging, biolabeling and photodynamic therapy.
Introduction
Hexanuclear molybdenum cluster complexes with the general
formula [{Mo6X8}L6]
n (X = Cl, Br, or I; L = various inorganic or
organic ligands) (Fig. 1) have recently attracted significant interest
in the context of application in biomedical technologies.1–3
This is due to an outstanding balance of physical and
chemical properties that these materials oﬀer. Firstly, similar
to their structural analogues, hexarhenium clusters [{Re6Q8}L6]
m
(Q = S or Se), these complexes demonstrate high chemical and
photostability of the cluster cores {Mo6X8}
4+ that are primarily
responsible for their triplet excited state photoluminescence
(i.e. phosphorescence). Secondly, their broad emission spectra
extend in the red/near infra-red region (from B550 to more
than 950 nm)4–13 overlapping the so-called ‘‘optical tissue
window’’ (650–900 nm), where the boundaries of the region
are defined by the minimal light absorption of hemoglobin
(o650 nm) and water (4900 nm).14 Thirdly, such complexes
are characterised by impressive photoluminescence quantum
yields (PLQYs) for inorganic compounds.4,5,11,15 Additionally,
the metal cluster complexes can also act as powerful photo-
sensitisers in the singlet oxygen (1O2) generation,
5–8,16–18 which
Fig. 1 Representation of the [{Mo6X8}L6]
n cluster complex.
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makes them especially interesting for applications associated
with the generation of singlet oxygen in vivo, such as, for example,
photodynamic therapy (PDT).19–22 Fourthly, the cluster complexes
are inherently highly electron dense and therefore can be used
as contrast agents in transmission electron microscopy (TEM)
and X-Ray imaging.23 Finally, the low toxicity of the molybdenum
octahedral cluster complexes and derivedmaterials was evidenced
by different research groups.24–26
All together these properties make hexamolybdenum cluster
complexes very attractive for biomedical applications (e.g. biolabeling
and diagnostic bioimaging), and therapeutic (PDT agents) and even
combined diagnostic and therapeutic (theranostic) applications.27
Despite the mentioned potential for biomedical applications,
the known hexamolybdenum cluster complexes themselves are
not ideally suited for these purposes. Most of them are either
insoluble in water or, after being dissolved in water, they hydro-
lyse forming insoluble products. Both the poor water solubility
and the susceptibility to hydrolysis hinder the application of
molybdenum metal cluster complexes within a physiological
environment.
The necessary water solubility could be achieved by the
ligation of the {Mo6X8}
4+-cluster core with hydrophilic ligands,
by analogy with hexarhenium cluster complexes.23,28–33 Indeed,
this approach was successfully realised with the use of inorganic
hydrophilic ligands NCS and N3
.25,30 However, these ligands
do not protect the molybdenum cluster from the hydrolysis. To
avoid the possible exchange of the ligands L by water molecules
or OH ions and simultaneously achieve biocompatibility, the
molybdenum metal cluster complex can be encapsulated within
an inert biocompatible carrier matrix, such as polystyrene (PS)
micro-beads11,18,26 or SiO2.
5,24,34,35 Despite the significant progress
made in the development of PS and SiO2 supported metal cluster
complexes, biological properties were not sufficiently studied
for any of the above materials apart from the cytotoxicity of
{Mo6I8}@PS-SH, which demonstrated low toxicity to Hep-2 human
epidermoid larynx carcinoma,26 and Cs2[{Mo6Br8}Br6]@SiO2,
which showed moderate toxicity to Caco-2 gut epithelial cells
and MRC-5 lung fibroblasts.24
To fill this lapse, we selected silica nanoparticles (SNPs) of two
diﬀerent compositions – {Mo6I8}
0:001@SiO2 and {Mo6I8}
0:01@SiO2
(Fig. 2 and Fig. S1–S3, ESI†) – prepared according to an earlier
described method from [{Mo6I8}(NO3)6]
2 bearing labile nitrato
ligands as a convenient source of {Mo6I8}
4+.35 Although the cluster
loading in the particles is quite low, the particles demonstrate
decent PLQY values (0.12 and 0.03, respectively) and relatively
good efficiencies of singlet oxygen generation.35 The particles
also have an optimal size of 50 nm and shape for biological
studies.36–39 In order to evaluate the potential of {Mo6I8}@SiO2
for bioimaging and/or photodynamic activity, we studied their
ability to be internalised into Hep-2 cells, cellular distribution
and cellular efflux degree and bench-marked them against
similar neat SiO2 particles.
40 We also studied the toxicity of
{Mo6I8}@SiO2 for Hep-2 cells in the darkness and upon light
irradiation.
Results and discussion
Cell viability and proliferation of SNPs
The eﬀect of neat SiO2, {Mo6I8}
0:001@SiO2 and {Mo6I8}
0:01@SiO2
nanoparticles on viability of Hep-2 cells was evaluated by the
MTT assay.41 The percentage of the metabolically active cells
was determined against the negative control. It was shown that
SNPs in the concentration range from 0.0015 to 0.375 mg mL1
did not influence the viability of the cells. However, the increase
of concentration of all types of SNPs above 0.75 mg mL1 caused
a slight reduction of the number of metabolically active cells
down to 80% (Fig. 3).
We also studied the influence of SNPs on the viability and
proliferation of Hep-2 cells and their apoptosis degree using dual
staining with Hoechst 33342/propidium iodide (PI). A represen-
tative fluorescence microscopy image of cells (Fig. 4) shows the
morphological changes of the Hep-2 cells. We found that the
treatment of the cells with 0.02 to 0.18 mg mL1 of cluster-doped
SNPs aﬀected neither cell density nor cell viability (Fig. 5). This
finding agrees well with the data of the MTT assay. However, we
observed that treatment of cells with {Mo6I8}@SiO2 nanoparticles
taken in the concentration range of 0.375–1.5 mg mL1 led to
a decrease of the cell density. The usable concentrations of
{Mo6I8}@SiO2 for practical biomedical applications are thus
recommended to not exceed 0.18 mg mL1.
Cellular uptake and elimination kinetics
The quantitative analyses of the cellular uptake and elimination
kinetics of SNPs were carried out using flow cytometry (FACS).
The Hep-2 cells were treated with {Mo6I8}@SiO2 nanoparticles at
a concentration of 0.1 mg mL1. According to FACS data, the
Fig. 2 TEM images of neat SiO2 and {Mo6I8}@SiO2 NPs.
Fig. 3 Viability of Hep-2 cells incubated with neat SiO2 and {Mo6I8}@SiO2
NPs determined by MTT assay.
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luminescence intensity of the treated cells was found to be much
higher than that of the untreated control cells. To determine the
kinetics of {Mo6I8}@SiO2 uptake by the cells we plotted the mean
photoluminescence intensity of the cells vs. the incubation time
(Fig. 6A). Maximal cellular uptake of both types of photolumi-
nescent SNPs was observed after 2 h of incubation, after which it
plateaued and did not significantly change for up to 24 h. Since
themaximal accumulation of SNPs occurred after 2 h of incubation,
the study of {Mo6I8}@SiO2 cellular elimination kinetics was
performed on the cells incubated for this period of time (Fig. 6B).
It was shown that SNPs are actively excreted during the first 2 h,
after that the photoluminescence intensity of the incubated
cells did not significantly change and remained at a high level
thereafter. Thus, our findings suggest both that SNPs rapidly
enter the cells and remain there for a long time and that the
loading of the metal cluster in SNPs does not aﬀect the rate of
internalisation and eﬄux of the particles.
Cellular internalisation and intracellular distribution
While FACS provides valuable quantitative data of the uptake and
eﬄux, it however lacks the ability to determine the intracellular
distribution of the particles. In order to determine the cellular
distribution of {Mo6I8}@SiO2 nanoparticles we visualised the
cells by confocal microscopy and TEM. Upon confocal micro-
scopy imaging of the treated cells (lex = 405 nm) we indeed
observed the intense red photoluminescence located in the cells
(Fig. 7 and Fig. S4, ESI†). Moreover, Z-stack analysis (Fig. S5, ESI†)
clearly showed that the fluorescence intensity is located inside
the cells, confirming that SNPs entered the cells and were not just
adherent on the cell surface. Specifically, confocal microscopy
revealed that localisation of SNPs was in the cell cytoplasm, on
the periphery of the cell and in the space near the nuclei.
TEM imaging of the cells incubated with SNPs under identical
conditions as for confocal microscopy assay gave us even more
Fig. 4 Representative image that shows the morphological changes of
Hep-2 cells after incubation with {Mo6I8}
0:001@SiO2 (1.5 mg mL
1), as
detected by dual staining by Hoechst 33342/PI.
Fig. 5 Eﬀect of neat SiO2 and {Mo6I8}@SiO2 NPs on the viability and
proliferation of Hep-2 cells determined by dual staining with Hoechst
33342/PI.
Fig. 6 (A) Kinetics of {Mo6I8}@SiO2 NP uptake by Hep-2 cells. (B) Cellular
elimination kinetics of {Mo6I8}@SiO2 NPs.
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details on localisation of the particles within the Hep-2 cells
and also some initial ideas about the possible cellular uptake
mechanisms. TEM images did not show any signs of abnormal
changes of the cell ultrastructure.We also observed no diﬀerence in
the intracellular distribution between neat SiO2, {Mo6I8}
0:001@SiO2
and {Mo6I8}
0:01@SiO2. TEM images showed that SNPs were
mostly located within membrane-enclosed vesicles of diﬀerent
sizes, i.e. endosomes (Fig. 8, Fig. S6 and S7, ESI†). Also zeta-
potential measurements of neat SiO2, {Mo6I8}
0:001@SiO2 and
{Mo6I8}
0:01@SiO2 showed that they all had negative charges
with the corresponding values of 23 2 mV, 40 1 mV, and
21  1 mV. These supported the general assumption that silica
particles entered the cells by the endocytosis mechanism.42,43
However, alternative mechanisms such as, for example, uptake
with the extracellular fluid by micropinocytosis are also
possible.44 In some cases, we also observed free SNPs in the
cytosol that could be due to some mechanism of endosomal
escape. We also observed free SNPs localised in the cytosol near
the nucleus. Such localisation may cause stronger eﬀects of SNPs
directly on the nucleus (for example, upon photoirradiation),
even if SNPs themselves do not enter the nucleus.
Therefore, exact mechanisms of cellular uptake and eﬄux still
need to be determined to fully evaluate potential of SNPs for
biomedical applications.
In vitro photodynamic toxicity
Having established that molybdenum cluster-doped SNPs can
easily enter the cells and remain within for suﬃciently a long
time and also that they show low toxicity in the darkness, we were
keen to examine whether these SNPs could be used as a tool for
intercellular photosensitisation. To do that we first confirmed
the generation of singlet oxygen by the SNPs after photoirradia-
tion in Hep-2 cells (Fig. S9, ESI†) and then the photodynamic
toxicity was studied. Hep-2 cells were treated with neat SiO2,
{Mo6I8}
0:001@SiO2 and {Mo6I8}
0:01@SiO2 in concentrations
from 0.0125 to 0.22 mg mL1, i.e. in the range where both
neat and doped SNPs did not show any cellular toxicity in the
darkness as it was shown by cytotoxicity assay (Fig. 3). As a
positive control, Hep-2 cells were also treated with the
second-generation commercial photosensitiser Radachlorin
at concentrations typical for in vitro experiments.45 Both
treated cells and untreated negative control cells were then
irradiated by light with l Z 400 nm and evaluated using
viability, apoptosis and proliferation assay.
The microscopy images (Fig. 9 and Fig. S8, ESI†) clearly
showed that Hep-2 cells in groups without irradiation and in
the negative control group and SiO2 after irradiation had a
spindle shape, were in close contact with neighbouring cells
and adhered to the surface of the culture flask. The images have
also shown that Hep-2 cells treated with cluster-doped SNPs in
concentrations above 0.18 mg mL1 became condensed and
rounded after light irradiation (Fig. S8 (B.7–B.9), ESI†).
The eﬀect of concentration of the photosensitisers on the cells
is demonstrated in Fig. 10. Namely, the graphs show that the
number of apoptotic cells was the highest after the Hep-2 cells
were treated with 0.0125–0.05 mg mL1 of {Mo6I8}
0:001@SiO2,
0.05 mg mL1 of {Mo6I8}
0:01@SiO2 and 0.01525 mg mL
1 of
Fig. 7 Cellular uptake of cluster-doped SNPs by confocal fluorescence
microscopy. Diﬀerential interference contrast (DIC) (A, D and G), red
fluorescence (B, E and H), and merged images (C, F and I).
Fig. 8 TEM image of a Hep-2 cell after incubation with 0.1 mg mL1 of
{Mo6I8}
0:001@SiO2 for 24 hours at 37 1C. (A) General view of the Hep-2 cell.
(B)–(D) Higher magnification image of the area indicated by the box B–D
in A, respectively. SNPs in the endosome are indicated by the asterisk, and
free SNPs in cytoplasm are indicated by the arrow. (C.1) and (D.1) higher
magnification bright field image of the area indicated by the box C and D in
the image A. (C.2) Si L2,3-edge, EF-TEM elemental map shows concen-
trated regions of silicon and (D.2) Mo L2,3-edge, EF-TEM elemental map
shows concentrated regions of molybdenum. (C.3) and (D.3) demonstrate
the localisation of SNPs in the cell. Similarity between elemental maps for
Si (C.2) and Mo (D.2) confirms that we visualised {Mo6I8}
0:001@SiO2
nanoparticles.
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Radachlorin. Moreover, the number of dead cells clearly
increased in the samples treated with {Mo6I8}
0:001@SiO2 in the
concentrations above 0.18 mg mL1, with {Mo6I8}
0:01@SiO2 in
the concentrations above 0.025 mg mL1 and Radachlorin in the
concentrations above 0.01525 mg mL1 (Fig. 10 and Fig. S8(B),
ESI†).
We were also able to determine IC50 for {Mo6I8}
0:01@SiO2 and
Radachlorin under light irradiation (0.075  0.007 mg mL1 and
0.021  0.002 mg mL1, respectively), while we detected only
B35% of dead cells in culture samples treated with
{Mo6I8}
0:001@SiO2 taken at a concentration of 0.22 mg mL
1.
Thus, SNPs with the higher loading of the metal cluster demon-
strated the stronger photodynamic cytotoxicity. This photodynamic
cytotoxicity is of the same order of magnitude as a currently
available photosensitiser Radochlorin, which was previously used
for fluorescence diagnosis and photodynamic therapy of malignant
tumours.46,47 We believe that the photo-induced cytotoxic eﬀect of
{Mo6I8}
0:001@SiO2 and {Mo6I8}
0:01@SiO2 is caused mostly by free
particles rather than the ones localised in endosomes, since they
extend the cytotoxic eﬀect of ROS within the cytoplasm. Moreover,
there is also a possibility that the molybdenum-cluster-doped
SNPs could facilitate endosomal escape. Specifically, short-living
and highly reactive singlet oxygen generated by {Mo6I8}@SiO2
upon photoirradiation could destroy the endosomal/lysosomal
membrane and enable the contents of the organelles to be
delivered to the cytosol. Indeed, some earlier works have already
shown that photoactive moieties, either alone or incorporated into
nanoparticles, can be used to disrupt the endosomal membrane
upon exposure to light, consequently facilitating the endosomal
escape.48,49
To summarise, the viability of the untreated cells under
irradiation was found to be 100%. As expected, neat SNPs did
not show any photoinduced cytotoxicity in the chosen range of
concentrations. The irradiation of the cells treated with
{Mo6I8}@SiO2 demonstrated a concentration-dependent decrease
in cellularity and a corresponding increase in the number of dead
cells (Fig. 10). SNPs with the higher load of the metal cluster
showed increased photoinduced cellular toxicity, comparable
with the commercially available photosensitiser Radachlorin.
To the best of our knowledge, this is the first in vitro study that
demonstrates the cytotoxicity of materials based on Mo6 metal
clusters upon photoirradiation. This study, thus, provides the
first experimental evidence of the potential of these and similar
materials for applications associated with the generation of
singlet oxygen in vivo, such as PDT.
Experimental
Synthesis of the nanoparticles
Nanoparticles {Mo6I8}
0:001@SiO2 and {Mo6I8}
0:01@SiO2 with an
average particle size of 50 nm were synthesised according to an
earlier described method. In general, (Bu4N)2[{Mo6I8}(NO3)6]
11
(1.7 or 17 mg, respectively) dissolved in ethanol (2.5 mL) was
Fig. 9 Eﬀect of {Mo6I8}
0:01@SiO2 (0.1 mg mL
1) on Hep-2 cells before
(top) and after (bottom) photoirradiation determined by dual staining with
Hoechst 33342/PI.
Fig. 10 Viability of Hep-2 cells treated with SNPs (SiO2, {Mo6I8}
0:001@SiO2
and {Mo6I8}
0:01@SiO2) after photoirradiation (l Z 400 nm, 30 min) deter-
mined by dual staining with Hoechst 33342/PI.
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added to the distilled water (2.5 mL). To prepare amicroemulsion,
both the ethanol/water solution of (Bu4N)2[{Mo6I8}(NO3)6]
(1.6 mL) and 25% aqueous ammonia solution (1.3 mL) were
added to the mixture of n-heptane (47 mL) and Brij L4 surfactant
(15 mL). This mixture was stirred for 30 min to ensure the
homogeneity of themicroemulsion. Finally, tetraethyl orthosilicate
(2 mL) was added and the mixture was stirred for 72 h. Thereafter,
the obtained yellowish colloidal solution was centrifuged (7000 rpm
for 10 min), washed successively with ethanol, water and acetone
and dried at 60 1C in air. Neat SiO2 nanoparticles were obtained
by the same method, but without (Bu4N)2[{Mo6I8}(NO3)6].
Cell culture
The human larynx carcinoma cell line (Hep-2) was purchased
from the State Research Center of Virology and Biotechnology
VECTOR and cultured in Eagle’s Minimum Essential Medium
(EMEM, pH = 7.4) supplemented with a 10% fetal bovine serum
under a humidified atmosphere (5% CO2 and 95% air) at 37 1C.
MTT-assay
The eﬀect of SNPs (neat SiO2, {Mo6I8}
0:001@SiO2 and
{Mo6I8}
0:01@SiO2) on the cell metabolic activity was determined
using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide (MTT) colorimetric assay. The Hep-2 cells were seeded
into 96-well plates at 5 103 cells per well in a medium containing
SNPs with concentrations from 0.0015 to 1.5 mg mL1 and then
incubated for 24 h under a 5% CO2 atmosphere. 10 mL of the
MTT solution (5 mg mL1) was added to each well, the plates
were incubated for 4 h and then the formazan formed was
dissolved in DMSO (200 mL). The optical density was measured
using a plate reader Multiskan FC (Thermo scientific, USA) at a
wavelength of 620 nm. The experiment was repeated three
times on separate days.
Viability, apoptosis and proliferation assay
Cell viability, apoptosis and proliferation were detected by Hoechst
33342/PI staining as previously described by Lee et al.50 The Hep-2
cells were seeded on 96-well plates at 5  103 cells per well in a
medium containing SNPs (neat SiO2 and {Mo6I8}@SiO2) at con-
centrations from 0.0015 mg mL1 to 1.5 mg mL1 and incubated
for 24 h. The cells incubated in the absence of SNPs were used as a
control. Treated cells and control cells were stained with Hoechst
33342 (Sigma-Aldrich) for 30 min at 37 1C and PI (Sigma-Aldrich)
for 10 min at 37 1C. An IN Cell Analyzer 2200 (GE Healthcare, UK)
was used to perform automatic imaging of six fields per well under
200magnification, in brightfield and fluorescence channels. The
images produced were used to analyse live, apoptotic and dead
cells among the whole population using the IN Cell Investigator
software (GE Healthcare, UK).
Cellular uptake kinetics
Hep-2 cells were seeded in 6-well plates at 3  105 cells per well
for each time point and were incubated for 24 h to reach a
confluency of greater than 50%. SNPs were diluted in EMEM
medium to a final concentration of 0.1 mg mL1 and were
sonicated for approximately 15 min prior to all experiments.
The cells were then treated with {Mo6I8}@SiO2 in culturemedium
for 0, 0.25, 0.5, 1, 2, 4 and 8 h at 37 1C under a 5% CO2
atmosphere. After treatment, cells were rinsed three times with
ice cold phosphate buﬀered saline (PBS) to remove any free SNPs.
Cells were then trypsinized and resuspended in fresh PBS with
10% FBS.
Cell suspensions were analysed using a FACSCanto II (Becton
Dickinson, USA). A 488 nm excitation source was used with a
695 nm emission filter. Gating was utilised using a negative
sample and the data were expressed as the median fluorescence
intensity. All of the data were the mean fluorescence obtained
from a population of 10 000 cells.
Cellular elimination kinetics
Hep-2 cells were seeded in 6-well plates at 3  105 cells per well
for each time point (0, 0.25, 0.5, 1, 2, 4 and 24 h) and were
incubated for 24 h to reach a confluency of greater than 50%.
{Mo6I8}@SiO2 was diluted in EMEM medium to a final concen-
tration of 0.1 mg mL1 and was sonicated for approximately
15 min prior to all experiments. The cells were then exposed to
{Mo6I8}@SiO2 in culture medium for 2 h at 37 1C under a 5% CO2
atmosphere. After treatment, the medium containing SNPs was
then replaced with a fresh medium and cells were incubated for
0.25, 0.5, 1, 2, 4 and 24 h. Cells were then trypsinized and
resuspended in fresh PBS with 10% FBS.
Cell suspensions were analysed using a FACSCanto II (Becton
Dickinson, USA). A 488 nm excitation source was used with a
695 nm emission filter. Gating was utilised using a negative
sample and the data were expressed as the median fluorescence
intensity. All of the data were the mean fluorescence obtained
from a population of 10 000 cells.
Confocal laser scanning microscopy
Hep-2 cells were seeded on slides (1.5  105 cells per slide) and
incubated overnight at 37 1C under a 5% CO2 atmosphere. The
medium was then replaced with a fresh medium containing
0.1 mg mL1 of {Mo6I8}@SiO2 and incubated for 24 h. The cells
incubated in the absence of SNPs were used as a control. Finally,
the cells were washed twice with PBS, fixed in 4% paraformaldehyde,
and washed thrice with PBS. Cells were visualised by using a Zeiss
LSM 510 confocal microscope (Carl Zeiss Inc., Jena, Germany)
equipped with a laser diode (405 nm) for fluorescence and with
a 100 oil immersion objective. The images were obtained and
analysed using ZEN 2009 software. Each experiment was repeated
three times on separate days.
Transmission electron microscopy (TEM)
Hep-2 cells were grown in a 25 cm2 culture flask (6 105 cells per
flask) for 24 h, after which the cells were exposed to 0.1 mg mL1
of SNPs for 24 h. Cells were washed with PBS and trypsinized.
Then 1 mL medium containing 1  106 cells was pipetted into
BEEM capsules. Cells were centrifuged at 1000 g for 5 min at
room temperature to form a pellet at the bottom of the capsule.
The cells were fixed with 2% glutaraldehyde in PBS for 2 h,
followed by two 30 min PBS washes. 1% osmium tetroxide in PBS
(1 mL) was added to the fixed cell pellet for 1 h. Then the samples
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were treated according to the general protocols for TEM. The full
protocol was previously described by Schrand et al.51 The ultrathin
sections (70 nm) without additional staining by uranyl acetate and
lead citrate were viewed on a Libra 120 (Zeiss) TEM operating at
120 kV. Energy-filtered transmission electron microscopy (EF-
TEM) elemental maps were recorded using the standard three
window technique described in Brydson, Electron Energy Loss
Spectroscopy, BIOS: Oxford (2001).
Evaluation of the photodynamic cytotoxicity
The Hep-2 cells were seeded in 96-well plates at the density of
5  103 cells per well and cultured for 24 h. The medium was
then replaced with the fresh medium containing from 0.0125 to
0.22 mg mL1 of neat SiO2 and {Mo6I8}@SiO2, incubated for 2 h
and then irradiated by a 500 W halogen lamp (l Z 400 nm) for
30 min to apply a total light dose of 20 J cm2. The photosensitiser
for the positive control (Radachlorins) was purchased from
the RADA-PHARMA group (RADA-PHARMA Co, Ltd, Moscow,
Russia). Radachlorin was used at concentrations typical for
in vitro studies (0.0025–0.1 mg mL1).45 Cells cultured in the
medium without SNPs served as a negative control. The viability
of treated and control cells was assayed and analysed 24 h
later using viability, apoptosis and proliferation assay as
described above.
Statistical analysis
Statistical analyses were performed using the Mann–Whitney
U test for unpaired data and P values of less than 0.01 were
considered as significant. Data are presented as mean  SEM
(standard error of the mean).
Conclusions
In this work, we established that SNPs doped by photolumi-
nescent molybdenum cluster {Mo6I8}
4+ had low cellular toxicity
in the darkness and high biocompatibility. In the similar
manner as neat SNPs, photoluminescent SNPs rapidly entered
the cells (presumably via endocytosis) and remained in the
cytoplasm for a long time. Internalised into Hep-2 cells, particles
showed significant photoluminescence in the red region even
after maximal elimination, as it was demonstrated by confocal
imaging and FACS studies. Experiments on photoirradiation
of the cells incubated with {Mo6I8}@SiO2 nanoparticles unam-
biguously showed high photoinduced cellular toxicity of
the materials. Moreover, particles with the higher loading
of the metal cluster were more toxic to Hep-2 cells upon
photoirradiation.
Consequently, we suggest that photoluminescent {Mo6I8}@
SiO2 nanoparticles have good potential for applications in in vitro
bioimaging and cellular photosensitisation, studies on oxidative
stress, or PDT. Therefore, the future research will focus on the
ways to further improve the PLQYs of the hybrid materials by,
for example, developing and immobilisation of labile/non-labile
mixed-ligand cluster complex precursors and the surface functiona-
lisation of the particles by specific ligands and/or biological cargos.
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